Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.
Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, O'Mahony D, Janik JE, Bittencourt AL, Taylor GP, Yamaguchi K, Utsunomiya A, Tobinai K, Watanabe T. Tsukasaki K, et al. Among authors: utsunomiya a. J Clin Oncol. 2009 Jan 20;27(3):453-9. doi: 10.1200/JCO.2008.18.2428. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064971 Free PMC article.
Adult T-cell leukemia: future prophylaxis and immunotherapy.
Kannagi M, Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Masuda M. Kannagi M, et al. Among authors: utsunomiya a. Expert Rev Anticancer Ther. 2004 Jun;4(3):369-76. doi: 10.1586/14737140.4.3.369. Expert Rev Anticancer Ther. 2004. PMID: 15161436 Review.
CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified.
Ishida T, Inagaki H, Utsunomiya A, Takatsuka Y, Komatsu H, Iida S, Takeuchi G, Eimoto T, Nakamura S, Ueda R. Ishida T, et al. Among authors: utsunomiya a. Clin Cancer Res. 2004 Aug 15;10(16):5494-500. doi: 10.1158/1078-0432.CCR-04-0371. Clin Cancer Res. 2004. PMID: 15328188
Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma.
Okamura J, Utsunomiya A, Tanosaki R, Uike N, Sonoda S, Kannagi M, Tomonaga M, Harada M, Kimura N, Masuda M, Kawano F, Yufu Y, Hattori H, Kikuchi H, Saburi Y. Okamura J, et al. Among authors: utsunomiya a. Blood. 2005 May 15;105(10):4143-5. doi: 10.1182/blood-2004-11-4193. Epub 2005 Jan 21. Blood. 2005. PMID: 15665110 Free article.
Tumor immunity against adult T-cell leukemia.
Kannagi M, Harashima N, Kurihara K, Ohashi T, Utsunomiya A, Tanosaki R, Masuda M, Tomonaga M, Okamura J. Kannagi M, et al. Among authors: utsunomiya a. Cancer Sci. 2005 May;96(5):249-55. doi: 10.1111/j.1349-7006.2005.00050.x. Cancer Sci. 2005. PMID: 15904464 Free article. Review.
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
Watanabe M, Ohsugi T, Shoda M, Ishida T, Aizawa S, Maruyama-Nagai M, Utsunomiya A, Koga S, Yamada Y, Kamihira S, Okayama A, Kikuchi H, Uozumi K, Yamaguchi K, Higashihara M, Umezawa K, Watanabe T, Horie R. Watanabe M, et al. Among authors: utsunomiya a. Blood. 2005 Oct 1;106(7):2462-71. doi: 10.1182/blood-2004-09-3646. Epub 2005 Jun 14. Blood. 2005. PMID: 15956280 Free article.
Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
Tobinai K, Watanabe T, Ogura M, Morishima Y, Ogawa Y, Ishizawa K, Minami H, Utsunomiya A, Taniwaki M, Terauchi T, Nawano S, Matsusako M, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Hayashi M, Seriu T, Hotta T. Tobinai K, et al. Among authors: utsunomiya a. J Clin Oncol. 2006 Jan 1;24(1):174-80. doi: 10.1200/JCO.2005.03.9313. Epub 2005 Dec 5. J Clin Oncol. 2006. PMID: 16330664 Clinical Trial.
Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors.
Inagaki A, Ishida T, Ishii T, Komatsu H, Iida S, Ding J, Yonekura K, Takeuchi S, Takatsuka Y, Utsunomiya A, Ueda R. Inagaki A, et al. Among authors: utsunomiya a. Int J Cancer. 2006 Jun 15;118(12):3054-61. doi: 10.1002/ijc.21688. Int J Cancer. 2006. PMID: 16425276 Free article.
388 results